Barclays’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-32,097
| Closed | -$130K | – | 4347 |
|
|
2023
Q4 | $130K | Buy |
32,097
+24,265
| +310% | +$98.3K | ﹤0.01% | 3646 |
|
|
2023
Q3 | $21K | Sell |
7,832
-533
| -6% | -$1.43K | ﹤0.01% | 3900 |
|
|
2023
Q2 | $77K | Sell |
8,365
-4,628
| -36% | -$42.6K | ﹤0.01% | 3501 |
|
|
2023
Q1 | $115K | Buy |
12,993
+4,089
| +46% | +$36.2K | ﹤0.01% | 3457 |
|
|
2022
Q4 | $44K | Buy |
8,904
+3,844
| +76% | +$19K | ﹤0.01% | 3819 |
|
|
2022
Q3 | $29K | Sell |
5,060
-132
| -3% | -$757 | ﹤0.01% | 3828 |
|
|
2022
Q2 | $29K | Sell |
5,192
-1,018
| -16% | -$5.69K | ﹤0.01% | 3955 |
|
|
2022
Q1 | $72K | Buy |
+6,210
| New | +$72K | ﹤0.01% | 3830 |
|